NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Importance of blood-collection tubes in plasma lidocaine determinations.

Author(s): Stargel WW, Roe CR, Routledge PA, Shand DG

Publication: Clin Chem, 1979, Vol. 25, Page 617-9

PubMed ID: 380842 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of blood or plasma contact with collection tube stoppers on lidocaine concentration.

Conclusion of Paper

There was a significant decrease in measured lidocaine when whole blood, but not plasma was added to red or green Vacutainer or red Monoject tubes. The effect of using plastic Vacutainer tubes versus an all glass system decreased as lidocaine concentration increased. However, in plastic Vacutainer tubes or an all glass system, increasing lidocaine concentration decreased the ratio of lidocaine in blood to lidocaine in plasma.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of blood or plasma contact with collection tube stoppers on lidocaine concentration. Clinical specimens and lidocaine spiked specimens from a normal volunteer were collected in plastic syringes and whole blood or plasma was then distributed to the various tubes.

    Summary of Findings:

    In 25 clinical specimens, contact of whole blood with the red stoppers on Vacutainer tubes resulted in a decrease in mean lidocaine concentration in serum from 6.5 ug/mL to 4.9 ug/mL (p<0.001). Similarly, there was a significant decrease in measured lidocaine when whole blood, but not plasma, was added to red or green Vacutainer or red Monoject tubes containing exogenous lidocaine. The effect of using plastic Vacutainer tubes versus an all glass system decreased as lidocaine concentrations increased. However, in plastic Vacutainer tubes or an all glass system, increasing lidocaine concentration decreased the ratio of lidocaine in blood to lidocaine in plasma. Finally, when blood was collected in Vacutainer tubes, lidocaine binding of plasma was 28%, versus 56% when blood was collected in glass.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    • Normal
    Platform:
    AnalyteTechnology Platform
    Small molecule Immunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Type of storage container Green Vacutainer
    Red Vacutainer
    Red Monoject
    All glass system
    Storage Storage conditions Without stopper
    In contact with stopper or with inversion
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Whole blood
    Preaquisition Biomarker level 2 ug/mL lidocaine
    4 ug/mL lidocaine
    6 ug/mL lidocaine
    8 ug/mL lidocaine
    10 ug/mL lidocaine
    12 ug/mL lidocaine

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...